Reimbursed

Film-coated tablets - 25 mg

Oral solution - 1 mg / ml

Tablets - 100 mg

Sugar coated tablets - 25 mg

Solution for injection - (50%) 1 g/2 ml

Solution for injection - (5%) 100 mg/2 ml

Tablets - 5 mg

Parkinsan contains the active substance trihexyphenidyl hydrochloride.

It is an antimuscarinic agent with similar effects as atropine.

It exerts direct inhibitory effect on the parasimpatique nervous system by inhibiting the effects of acetylcholine.

Parkinsan has also an antispasmodic effect on the smooth muscles.

Parkinsan 5 mg tablets are indicated:

  • as supportive treatment for all forms of parkinsonism (postencephalytic, artheriosclerotic and idiopathic);
  • as adjuvant therapy when treating the above-mentioned forms of parkinsonism with levodopa. It helps in reducing muscle rigidity and increased salivation that accompanies parkinsonism;
  • as adjuvant therapy when using levodopa to control extrapyramidal disorders due to central nervous system drugs.

Tablets - 5 mg

Solution for injection - (0.5%) 10 mg/2 ml

Oral drops, solution - (0.2%) 2 mg/ml

Haloperidol belongs to a group of medicines called ‘antipsychotics’.

Haloperidol is used in adults, adolescents and children for illnesses affecting the way you think, feel or behave. These include mental health problems (such as schizophrenia and bipolar disorder) and behavioural problems.

These illnesses may make you:

  • feel confused (delirium);
  • see, hear, feel or smell things that are not there (hallucinations);
  • believe things that are not true (delusions);
  • feel unusually suspicious (paranoia);
  • feel very excited, agitated, enthusiastic, impulsive or hyperactive;
  • feel very aggressive, hostile or violent.

In adolescents and children, Haloperidol is used to treat schizophrenia in patients aged 13 to 17 years, and to treat behavioural problems in patients aged 6 to 17 years.

Haloperidol is also used:

  • in adolescents and children aged 10 to 17 years and in adults for movements or sounds you can’t control (tics), for example in severe Tourette’s syndrome
  • in adults to help control movements in Huntington’s disease.

Haloperidol is sometimes used when other medicines or treatments have not worked or caused unacceptable side effects.

Sugar coated tablets - 25 mg

Film-coated tablets - 10 mg

Tablets - 200 mg

Solution for injection - (1%) 10 mg/ml

Sugar coated tablets - 100 mg

Solution for injection - (2.5%) 50 mg/2 ml

Tablets - 60 mg

Tablets - 15 mg

Luminal contains as active substance phenobarbital, which is part of the group of barbiturates. It may affect the brain activity at different levels, from excitation to mild sedation to hypnosis and coma. High therapeutic doses of barbiturates may produce anesthesia. Overdoses may cause death. Phenobarbital depresses the sensory cortex, decreases motor activity, alters cerebellar function and causes drowsiness, sedation and hypnosis. Barbiturates have poor analgesic activity in subanesthetic doses and may increase the response to painful stimuli. All barbiturates exhibit anticonvulsant action at anesthetic doses. Barbiturates are respiratory depressants. The degree of respiratory depression is dependent upon the dose. Barbiturates are absorbed in varying degrees following oral or parenteral administration. The salts are absorbed faster than the acids. The rate of absorption is increased if sodium salts are given as a dilute solution or taken on an empty stomach. The onset of action ranges from 20 to 60 minutes after oral administration. After intramuscular injection, the onset of action is more rapid, while after intravenous administration the action may start after 5 minutes. Maximal depression of central nervous system may not occur until 15 minutes after intravenous injection.

Luminal is used:

  • as long-term treatment of generalised tonic-clonic and focal-cortical seizures;
  • as part of the emergency treatment of acute convulsions, including status epilepticus;
  • as short-term treatment of insomnia;
  • as preanesthetic sedation;
  • in the treatment of febrile seizures in children.

Suppositories - 125 mg

 

Suppositories - 250 mg

 

Results 1 - 20 of 31